DE256116C - - Google Patents
Info
- Publication number
- DE256116C DE256116C DENDAT256116D DE256116DA DE256116C DE 256116 C DE256116 C DE 256116C DE NDAT256116 D DENDAT256116 D DE NDAT256116D DE 256116D A DE256116D A DE 256116DA DE 256116 C DE256116 C DE 256116C
- Authority
- DE
- Germany
- Prior art keywords
- putrefaction
- histidine
- imidazolylethylamine
- pure
- culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 5
- 241000894006 Bacteria Species 0.000 claims description 4
- 150000001412 amines Chemical class 0.000 claims description 3
- 244000005700 microbiome Species 0.000 claims description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims 2
- DEURIUYJZZLADZ-UHFFFAOYSA-N 2-(1h-imidazol-2-yl)ethanamine Chemical compound NCCC1=NC=CN1 DEURIUYJZZLADZ-UHFFFAOYSA-N 0.000 claims 1
- 241000700199 Cavia porcellus Species 0.000 claims 1
- 230000008021 deposition Effects 0.000 claims 1
- 238000001514 detection method Methods 0.000 claims 1
- 239000012153 distilled water Substances 0.000 claims 1
- 238000000605 extraction Methods 0.000 claims 1
- 238000011534 incubation Methods 0.000 claims 1
- 150000007523 nucleic acids Chemical class 0.000 claims 1
- 102000039446 nucleic acids Human genes 0.000 claims 1
- 108020004707 nucleic acids Proteins 0.000 claims 1
- 235000015097 nutrients Nutrition 0.000 claims 1
- 230000000144 pharmacologic effect Effects 0.000 claims 1
- 230000035479 physiological effects, processes and functions Effects 0.000 claims 1
- 229940075930 picrate Drugs 0.000 claims 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-M picrate anion Chemical compound [O-]C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-M 0.000 claims 1
- 229910052697 platinum Inorganic materials 0.000 claims 1
- 238000001556 precipitation Methods 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 210000000813 small intestine Anatomy 0.000 claims 1
- 238000002255 vaccination Methods 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- 229920001817 Agar Polymers 0.000 description 5
- 235000010419 agar Nutrition 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 239000001888 Peptone Substances 0.000 description 3
- 108010080698 Peptones Proteins 0.000 description 3
- 210000000496 pancreas Anatomy 0.000 description 3
- 235000019319 peptone Nutrition 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Chemical compound OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000012670 alkaline solution Substances 0.000 description 2
- VHRGRCVQAFMJIZ-UHFFFAOYSA-N cadaverine Chemical compound NCCCCCN VHRGRCVQAFMJIZ-UHFFFAOYSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000206672 Gelidium Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE256116C true DE256116C (cs) |
Family
ID=514162
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DENDAT256116D Active DE256116C (cs) |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE256116C (cs) |
-
0
- DE DENDAT256116D patent/DE256116C/de active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0012278A2 (de) | Herstellung von N-substituierten Derivaten des 1-Desoxy-nojirimycins | |
| DE256116C (cs) | ||
| DE3689174T2 (de) | Verfahren zur Herstellung von Riboflavin. | |
| DE1518382A1 (de) | Verfahren zur Herstellung von L-Alanin | |
| DE1231653B (de) | Verfahren zur Herstellung von 1-Homoserin auf fermentativem Wege | |
| DE228592C (cs) | ||
| DE1009583B (de) | Verfahren zur biochemischen Herstellung von 2-Keto-1-gulonsaeure | |
| DE252872C (cs) | ||
| DE2849393C2 (de) | Verfahren zur biotechnischen Herstellung von 2,5-Diketogluconsäure | |
| DE2366505C2 (de) | Verwendung des Stammes Pseudomonas ATCC 21973 zur in situ-Herstellung einer Aminotransferase | |
| DE1793806C2 (de) | Verfahren zur Herstellung von L-Alanin | |
| DE814890C (de) | Verfahren zur Herstellung von Butandiol-(2, 3) und Butanolon-(2, 3) durch Gaerung | |
| DE1107225B (de) | Verfahren zur Herstellung von 1, 4, 17(20)-Pregnatrienen | |
| DE1770167C3 (de) | Verfahren zur fermentativen Herstellung von Orotidylsäure | |
| DE2156339A1 (de) | Verfahren zur Herstellung von L-Asparaginase | |
| DE1795721C2 (de) | Verfahren zur fermentativen Herstellung von Orotidylsäure | |
| AT309661B (de) | Verfahren zum enzymatischen Enthaaren von geweichten Häuten mit proteolytischen Enzymen in alkalischer Flotte | |
| DE289687C (cs) | ||
| DE1939035C3 (de) | Verfahren zur Herstellung von Xylit auf mikrobiologischem Wege | |
| DE664428C (de) | Verfahren zur Herstellung von Gerbextrakten aus Sulfitcelluloseablauge | |
| DE1442118C (de) | Verfahren zur Herstellung von milchkoagulierendem Ferment durch Züchten von Schimmelpilzen | |
| DE1011578B (de) | Verfahren zur Herstellung von Laevan-Praeparaten | |
| DE3712539A1 (de) | Verfahren zur mikrobiellen herstellung von l-alpha-aminosaeuren | |
| DE1041896B (de) | Verfahren zur Herstellung von Aminosaeuren auf biotechnischem Wege | |
| DE1122949B (de) | Verfahren zur Herstellung von 16ª‡-Methyl-11ª‡,17ª‡-dioxy-4-pregnen-3,20-dion |